van de Schans, S A M <br/><br/>
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2012 
 - 1280-1286 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cause of Death<br/>Cyclophosphamide--adverse effects<br/>Disease Progression<br/>Doxorubicin--adverse effects<br/>Female<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Neoplasm Staging<br/>Netherlands--epidemiology<br/>Prednisone--adverse effects<br/>Registries--statistics & numerical data<br/>Standard of Care<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--adverse effects